Allergy Therapeutics plc (AGYTF) Stock Price & News

All values in GBP	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Revenue	10.51M	10.51M	18.14M	18.14M
Cost of goods sold	6.29M	6.29M	7.40M	7.40M
Cost of revenue	6.29M	6.29M	7.40M	7.40M
Research and development expenses	3.86M	3.86M	4.42M	4.42M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	9.47M	9.47M	10.71M	10.71M
Operating expense	15.42M	15.42M	16.43M	16.43M
Total operating expenses	21.71M	21.71M	23.83M	23.83M
Operating income	-11.20M	-11.20M	-5.69M	-5.69M
Other non operating income	-1.32M	-1.32M	-2.08M	-2.08M
EBT including unusual items	-13.92M	-13.92M	-9.66M	-9.66M
EBT excluding unusual items	-14.13M	-14.13M	-9.66M	-9.66M
Income tax expense	604.50K	604.50K	294.00K	294.00K
Effective tax rate	-4.34%	-4.34%	-3.04%	-3.04%
Other operating expenses	-436.50K	-436.50K	-273.00K	-273.00K
Net income	-14.52M	-14.52M	-9.96M	-9.96M
Net profit margin	-138.23%	-138.23%	-54.90%	-54.90%
Earnings per share	-	-	-	-
Interest and investment income	84.50K	84.50K	72.00K	72.00K
Interest expense	-1.70M	-1.70M	-1.97M	-1.97M
Net interest expenses	-1.62M	-1.62M	-1.90M	-1.90M
Depreciation and amortization charges	1.81M	1.81M	1.03M	1.03M
EBITDA	-11.01M	-11.01M	-4.61M	-4.61M
Gain or loss from assets sale	23.00K	23.00K	-	-

Finance